Search alternatives:
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 20,041 - 20,050 results of 20,050 for search '(( 59 ((0 decrease) OR (a decrease)) ) OR ( 50 ((ns decrease) OR (we decrease)) ))', query time: 0.82s Refine Results
  1. 20041
    Simulation and Optimization of an LNG Plant Cold Section

    Simulation and Optimization of an LNG Plant Cold Section by Katebah, Mary Anna

    Published 2018
    Get full text
    Get full text
    Save to List
    Saved in:
  2. 20042
    Driver Drowsiness Detection Study using Heart Rate Variability analysis in Virtual Reality Environment

    Driver Drowsiness Detection Study using Heart Rate Variability analysis in Virtual Reality Environment by Chowdhury, Muhammad E.H.

    Published 2018
    Get full text
    Get full text
    Save to List
    Saved in:
  3. 20043
    Table_1_Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF.docx

    Table_1_Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF.docx by Yanhong Guo (270212)

    Published 2022
    “…Among those 247 patients with MHD, 211 patients were already in treatment with angiotensin converting enzyme inhibitors (ACEi)/angiotensin receptor blockers (ARBs) before being treated with sacubitril/valsartan. We also performed an analysis to compare the differences between the 211 patients who had previously received ACEi/ARB treatment and the 36 patients who were sacubitril/valsartan naive.…”
    Save to List
    Saved in:
  4. 20044
    A single systemic prophylactic treatment with CpG-C results in long-term reduction of metastatic burden in the brain.

    A single systemic prophylactic treatment with CpG-C results in long-term reduction of metastatic burden in the brain. by Amit Benbenishty (6524375)

    Published 2019
    “…<p>(<b>a</b>) In the experimental metastasis models, we used the aECAi approach [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2006859#pbio.2006859.ref032" target="_blank">32</a>] for injection of tumor cells (see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2006859#sec002" target="_blank">Methods</a>): a method that improves brain targeting and preserves cerebral hemodynamics. …”
    Save to List
    Saved in:
  5. 20045
    FMRI data sets spanning the brain, brainstem, and spinal cord, from two pain studies of healthy females

    FMRI data sets spanning the brain, brainstem, and spinal cord, from two pain studies of healthy females by Patrick Stroman (2918633)

    Published 2020
    “…Data were acquired in 9 contiguous sagittal slices with a repetition time (TR) of 0.75 sec/slice, an echo time of 76 msec to optimize the T2-weighted BOLD sensitivity, and a 28 × 21 cm field-of-view with 1.5 × 1.5 × 2 mm3 resolution (45). …”
    Save to List
    Saved in:
  6. 20046
    Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

    Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 by Stein Emil, Vollset

    Published 2024
    Get full text
    Get full text
    Get full text
    Save to List
    Saved in:
  7. 20047
    Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

    Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 by Stein Emil, Vollset

    Published 2024
    Get full text
    Get full text
    Get full text
    article
    Save to List
    Saved in:
  8. 20048
    PDLB - Balance Sheet

    PDLB - Balance Sheet by Nguyen Linh (19516642)

    Published 2024
    “…</p><p><br></p><p dir="ltr">ECIP capital: PDLB received $225M of ECIP capital, and the regulators assigned them the lowest possible dividend (0.5%) on this capital for the first year of payments (announced in June). If we assume PDLB continues to pay 0.5% on this preferred and they have a cost of preferred equity of 10%, then we can calculate the value of this $225M liability as just $11M, with the rest a write-up to equity.…”
    Save to List
    Saved in:
  9. 20049
    Supplemental data of Glucocorticoid Dependent Mesenchymal Cell Differentiation is Required for Perinatal Lung Morphogenesis and Lung Function

    Supplemental data of Glucocorticoid Dependent Mesenchymal Cell Differentiation is Required for Perinatal Lung Morphogenesis and Lung Function by Yan Xu (6655778)

    Published 2020
    “…Cells were pelleted, counted and 50,000 cells per sample prepared for ATAC-seq at a depth of ~1,000,000 reads per sample. …”
    Save to List
    Saved in:
  10. 20050
    The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

    The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 by Khanh Bao, Tran

    Published 2022
    “…BackgroundUnderstanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. …”
    Get full text
    Get full text
    Get full text
    Save to List
    Saved in:

Search Tools: